Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00030004 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of Spinal Manipulation for Chronic Neck Pain
A Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Terminated
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00030004: Clinical Trial Phase 1 study, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00030004 is a Phase 1 study that was terminated before completion, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00030004, a Phase 1 study, was terminated before completion, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is designed to determine whether a medicine that can produce temporary amnesia (midazolam) can be used to block the memory of treatment with spinal manipulation. This is important since any study that is designed to determine whether spinal manipulation is effective would be better if patients were not aware of whether or not they were treated. This would allow a true assessment of treatment effects without the complication of a strong placebo effect that manipulative treatment may produce.
Interventions
- DRUG midazolam
- PROCEDURE spinal manipulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2000-05 |
| Est. Completion | 2001-04 |
| Phase | Phase 1 |
Why NCT00030004 stopped before completion
NCT00030004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 2 interventions - of which midazolam is the first listed.
NCT00030004 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00030004 about?
NCT00030004 is a clinical study titled "Pilot Study of Spinal Manipulation for Chronic Neck Pain". This study is designed to determine whether a medicine that can produce temporary amnesia (midazolam) can be used to block the memory of treatment with spinal manipulation. This is important since any study that is designed to determine whether spinal manipulation is effective would be better if pat...
What is the current status of trial NCT00030004?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2000-05. Estimated completion is 2001-04.
What interventions are being tested in trial NCT00030004?
The interventions under investigation include: midazolam (DRUG), spinal manipulation (PROCEDURE).
Who is sponsoring clinical trial NCT00030004?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00030004's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia